Distinct groups and antimicrobial resistance of clinical Stenotrophomonas maltophilia complex isolates from Korea

Journal of Medical Microbiology

Volumn 62, Issue PART5, 2013, Pages 748-753

  Ko, Kwan Soo ^b,c   Rhee, Ji Young ^a   Choi, Ji Young ^b   Choi, Myung Jin ^b   Song, Jae Hoon ^b,c   Peck, Kyong Ran ^a  

^a Dankook University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Asia Pacific Foundation for Infectious Diseases   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) B;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BROTH DILUTION; CLADISTICS; CLUSTER ANALYSIS; CONTROLLED STUDY; GENE SEQUENCE; KOREA; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS GENICULATA; PSEUDOMONAS HIBISCIOLA; STENOTROPHOMONAS; STENOTROPHOMONAS BETELI; STENOTROPHOMONAS MALTOPHILIA; STENOTROPHOMONAS PAVANII;

EID: 84876573902     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.053355-0     Document Type: Article

References (26)

1. Anzai, Y., Kim, H., Park, J. Y., Wakabayashi, H. & Oyaizu, H. (2000). Phylogenetic affiliation of the pseudomonads based on 16S rRNA sequence. Int J Syst Evol Microbiol 50, 1563-1589.
2. Berg, G., Roskot, N. & Smalla, K. (1999). Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia. J Clin Microbiol 37, 3594-3600.
3. Brooke, J. S. (2012). Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 25, 2-41.
4. Cho, H. H., Sung, J. Y., Kwon, K. C. & Koo, S. H. (2012). Expression of Sme efflux pumps and multilocus sequence typing in clinical isolates of Stenotrophomonas maltophilia. Ann Lab Med 32, 38-43.
5. Chung, H. S., Hong, S. G., Lee, Y., Kim, M., Yong, D., Jeong, S. H., Lee, K. & Chong, Y. (2012). Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital. Yonsei Med J 53, 439-441.
6. CLSI (2009). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically M07-A8; Approved Standard, 8th edn. Wayne, PA: Clinical and Laboratory Standards Institute.
7. CLSI (2011). Performance Standards For Antimicrobial Susceptibility Testing, 21st Informational Supplement, M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute.
8. Coenye, T., Vanlaere, E., LiPuma, J. J. & Vandamme, P. (2004a). Identification of genomic groups in the genus Stenotrophomonas using gyrB RFLP analysis. FEMS Immunol Med Microbiol 40, 181-185.
9. Coenye, T., Vanlaere, E., Falsen, E. & Vandamme, P. (2004b). Stenotrophomonas africana Drancourt et al. 1997 is a later synonym of Stenotrophomonas maltophilia (Hugh 1981) Palleroni and Bradbury 1993. Int J Syst Evol Microbiol 54, 1235-1237.
10. Farrell, D. J., Sader, H. S. & Jones, R. N. (2010). Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections. Antimicrob Agents Chemother 54, 2735-2737.
11. Garazi, M., Singer, C., Tai, J. & Ginocchio, C. C. (2012). Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review. J Hosp Infect 81, 114-118.
12. Gould, V. C., Okazaki, A., Howe, R. A. & Avison, M. B. (2004). Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates. J Antimicrob Chemother 54, 348-353.
13. Gould, V. C., Okazaki, A. & Avison, M. B. (2006). β-Lactam resistance and β-lactamase expression in clinical Stenotrophomonas maltophilia isolates having defined phylogenetic relationships. J Antimicrob Chemother 57, 199-203.
14. Kaiser, S., Biehler, K. & Jonas, D. A. (2009). A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure. J Bacteriol 191, 2934-2943.
15. Liaw, S. J., Lee, Y. L. & Hsueh, P. R. (2010). Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. Int J Antimicrob Agents 35, 126-130.
16. Looney, W. J., Narita, M. & Mühlemann, K. (2009). Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9, 312-323.
17. Minkwitz, A. & Berg, G. (2001). Comparison of antifungal activities and 16S ribosomal DNA sequences of clinical and environmental isolates of Stenotrophomonas maltophilia. J Clin Microbiol 39, 139- 145.
18. Nicodemo, A. C., Araujo, M. R., Ruiz, A. S. & Gales, A. C. (2004). In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods. J Antimicrob Chemother 53, 604-608.
19. Ramos, P. L., Van Trappen, S., Thompson, F. L., Rocha, R. C. S., Barbosa, H. R., De Vos, P. & Moreira-Filho, C. A. (2011). Screening for endophytic nitrogen-fixing bacteria in Brazilian sugar cane varieties used in organic farming and description of Stenotrophomonas pavanii sp. nov. Int J Syst Evol Microbiol 61, 926- 931.
20. Song, J. H., Sung, J. Y., Kwon, K. C., Park, J. W., Cho, H. H., Shin, S. Y., Ko, Y. H., Kim, J. M., Shin, K. S. & Koo, S. H. (2010). [Analysis of acquired resistance genes in Stenotrophomonas maltophilia]. Korean J Lab Med 30, 295-300 (in Korean).
21. Svensson-Stadler, L. A., Mihaylova, S. A. & Moore, E. R. (2012). Stenotrophomonas interspecies differentiation and identification by gyrB sequence analysis. FEMS Microbiol Lett 327, 15-24.
22. Tan, C. K., Liaw, S. J., Yu, C. J., Teng, L. J. & Hsueh, P. R. (2008). Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn Microbiol Infect Dis 60, 205-210.
23. Toleman, M. A., Bennett, P. M., Bennett, D. M. C., Jones, R. N. & Walsh, T. R. (2007). Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 13, 559-565.
24. Valdezate, S., Vindel, A., Martín-Dávila, P., Del Saz, B. S., Baquero, F. & Cantón, R. (2004). High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 42, 693-699.
25. Valenza, G., Tappe, D., Turnwald, D., Frosch, M., König, C., Hebestreit, H. & Abele-Horn, M. (2008). Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros 7, 123-127.
26. Wu, H., Wang, J. T., Shiau, Y. R., Wang, H. Y., Lauderdale, T. L. Y., Chang, S. C. & TSAR Hospitals (2012). A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan. J Microbiol Immunol Infect 45, 120-126.